BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12665429)

  • 1. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker.
    Schwöbel B; Alifrangis M; Salanti A; Jelinek T
    Malar J; 2003 Mar; 2():5. PubMed ID: 12665429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
    Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
    Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.
    Massamba L; Madamet M; Benoit N; Chevalier A; Fonta I; Mondain V; Jeandel PY; Amalvict R; Delaunay P; Mosnier J; Marty P; Pomares C; Pradines B
    Malar J; 2020 Jan; 19(1):37. PubMed ID: 31964401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.
    Pimentel S; Nogueira F; Benchimol C; Quinhentos V; Bom J; Varandas L; do Rosário V; Bernardino L
    Malar J; 2006 Apr; 5():30. PubMed ID: 16597338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
    Wichmann O; Muehlberger N; Jelinek T; Alifrangis M; Peyerl-Hoffmann G; Muhlen M; Grobusch MP; Gascon J; Matteelli A; Laferl H; Bisoffi Z; Ehrhardt S; Cuadros J; Hatz C; Gjorup I; McWhinney P; Beran J; da Cunha S; Schulze M; Kollaritsch H; Kern P; Fry G; Richter J;
    J Infect Dis; 2004 Nov; 190(9):1541-6. PubMed ID: 15478057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malarone treatment failure not associated with previously described mutations in the cytochrome b gene.
    Wichmann O; Muehlen M; Gruss H; Mockenhaupt FP; Suttorp N; Jelinek T
    Malar J; 2004 Jun; 3():14. PubMed ID: 15186499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
    Muehlen M; Schreiber J; Ehrhardt S; Otchwemah R; Jelinek T; Bienzle U; Mockenhaupt FP
    Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
    Khositnithikul R; Tan-Ariya P; Mungthin M
    Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
    Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
    Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of atovaquone and Malarone resistance conferring mutations in Plasmodium falciparum cytochrome b gene (cytb).
    Gil JP; Nogueira F; Strömberg-Nörklit J; Lindberg J; Carrolo M; Casimiro C; Lopes D; Arez AP; Cravo PV; Rosário VE
    Mol Cell Probes; 2003; 17(2-3):85-9. PubMed ID: 12788029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.
    Staines HM; Burrow R; Teo BH; Chis Ster I; Kremsner PG; Krishna S
    J Antimicrob Chemother; 2018 Mar; 73(3):581-595. PubMed ID: 29237012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria.
    Fivelman QL; Butcher GA; Adagu IS; Warhurst DC; Pasvol G
    Malar J; 2002 Feb; 1():1. PubMed ID: 12057021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
    Sutherland CJ; Laundy M; Price N; Burke M; Fivelman QL; Pasvol G; Klein JL; Chiodini PL
    Malar J; 2008 Nov; 7():240. PubMed ID: 19021900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia.
    Gebru T; Hailu A; Kremsner PG; Kun JF; Grobusch MP
    Malar J; 2006 Nov; 5():112. PubMed ID: 17118179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S; Gill MJ; Kain KC
    Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
    Basco LK
    Am J Trop Med Hyg; 2003 Aug; 69(2):179-83. PubMed ID: 14506774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of Cytochrome
    Lin JT; Waltmann A; Moser KA; Park Z; Na YB; Aydemir O; Brazeau NF; Gosi P; Marsh PW; Muller MS; Spring M; Sok S; Bailey JA; Saunders DL; Lon C; Wojnarski M
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct evidence for the atovaquone action on the Plasmodium cytochrome bc1 complex.
    Siregar JE; Kurisu G; Kobayashi T; Matsuzaki M; Sakamoto K; Mi-ichi F; Watanabe Y; Hirai M; Matsuoka H; Syafruddin D; Marzuki S; Kita K
    Parasitol Int; 2015 Jun; 64(3):295-300. PubMed ID: 25264100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.